Shanghai Haohai Biological Technology Co Ltd
SSE:688366

Watchlist Manager
Shanghai Haohai Biological Technology Co Ltd Logo
Shanghai Haohai Biological Technology Co Ltd
SSE:688366
Watchlist
Price: 62.46 CNY -6.09% Market Closed
Market Cap: 12B CNY
Have any thoughts about
Shanghai Haohai Biological Technology Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Shanghai Haohai Biological Technology Co Ltd

Wall Street analysts forecast Shanghai Haohai Biological Technology Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shanghai Haohai Biological Technology Co Ltd is 79.56 CNY with a low forecast of 78.78 CNY and a high forecast of 81.9 CNY.

Lowest
Price Target
78.78 CNY
26% Upside
Average
Price Target
79.56 CNY
27% Upside
Highest
Price Target
81.9 CNY
31% Upside
Shanghai Haohai Biological Technology Co Ltd Competitors:
Price Targets
KRYS
Krystal Biotech Inc
13% Upside
ZNTL
Zentalis Pharmaceuticals Inc
205% Upside
688235
Beigene Ltd
25% Upside
LVTX
LAVA Therapeutics NV
374% Upside
TVTX
Travere Therapeutics Inc
48% Upside
688278
Xiamen Amoytop Biotech Co Ltd
3% Upside
BIOPOR
Bioporto A/S
88% Upside
VXRT
Vaxart Inc
707% Upside

Revenue
Forecast

Revenue Estimate
Shanghai Haohai Biological Technology Co Ltd

For the last 6 years the compound annual growth rate for Shanghai Haohai Biological Technology Co Ltd's revenue is 12%. The projected CAGR for the next 3 years is 13%.

12%
Past Growth
13%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Shanghai Haohai Biological Technology Co Ltd

For the last 6 years the compound annual growth rate for Shanghai Haohai Biological Technology Co Ltd's operating income is 1%. The projected CAGR for the next 3 years is 28%.

1%
Past Growth
28%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Shanghai Haohai Biological Technology Co Ltd

For the last 6 years the compound annual growth rate for Shanghai Haohai Biological Technology Co Ltd's net income is 2%. The projected CAGR for the next 3 years is 11%.

2%
Past Growth
11%
Estimated Growth
Estimates Accuracy
4%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shanghai Haohai Biological Technology Co Ltd's stock price target?
Price Target
79.56 CNY

According to Wall Street analysts, the average 1-year price target for Shanghai Haohai Biological Technology Co Ltd is 79.56 CNY with a low forecast of 78.78 CNY and a high forecast of 81.9 CNY.

What is Shanghai Haohai Biological Technology Co Ltd's Revenue forecast?
Projected CAGR
13%

For the last 6 years the compound annual growth rate for Shanghai Haohai Biological Technology Co Ltd's revenue is 12%. The projected CAGR for the next 3 years is 13%.

What is Shanghai Haohai Biological Technology Co Ltd's Operating Income forecast?
Projected CAGR
28%

For the last 6 years the compound annual growth rate for Shanghai Haohai Biological Technology Co Ltd's operating income is 1%. The projected CAGR for the next 3 years is 28%.

What is Shanghai Haohai Biological Technology Co Ltd's Net Income forecast?
Projected CAGR
11%

For the last 6 years the compound annual growth rate for Shanghai Haohai Biological Technology Co Ltd's net income is 2%. The projected CAGR for the next 3 years is 11%.

Back to Top